MUMBAI & PRINCETON, N.J. & KING OF PRUSSIA, Pa. May 23, 2018 –(BUSINESS WIRE)–Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that…Original Article
Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
